Back to results
US 2022/0009967 A1Published application
Isolation and Semi-Synthesis of Rufomycin Analogs
AssigneeThe Board of Trustees of the University of Illinois
InventorScott G. Franzblau
Life of this patent
Estimating the term…
Abstract
Provided herein are compounds having a structure according to formula I, pharmaceutical compositions thereof, and methods of treating a bacterial infection thereof.
Claims20
A compound having a structure according to Formula I or a pharmaceutically acceptable salt thereof:
- wherein,
- R1 and R2, together are selected from
- R3 and R4 are independently selected from NO2, OH, OAc, OCH3, OBz, NH2, and
- or R3 and R4 together with the carbon atoms to which they are attached, form a five- to seven-membered substituted or unsubstituted heterocycloalkyl comprising 1 to 3 ring heteroatoms selected from O and N;
- R5 is selected from
- and,
- R6 is selected from H and C1-C3 alkyl;
- provided when R1 and R2 together are
- R3 is NO2, R4 is OH, and R5 is
- that R6 is not H;
- when R1 and R2 together are
- R3 is NO2, R4 is OH, and R5 is
- that R6 is not H;
- when R1 and R2 together are
- R3 is NO2, R4 is OH, and R5 is
- that R6 is not H;
- and when R1 and R2 together are
- R3 is NO2, R4 is OH, and R5 is
- that R6 is not H.
16 more elements
A compound or a pharmaceutically acceptable salt thereof having a structure selected from the group of
Dependencies are inferred from the claim text.